HKSE - Delayed Quote
HKD
InnoCare Pharma Limited (9969.HK)
11.310
-0.360
(-3.08%)
As of 2:13:48 PM GMT+8. Market Open.
Loading chart for 9969.HK
- Previous Close
11.670 - Open
11.560 - Bid 11.300 x --
- Ask 11.320 x --
- Day's Range
11.270 - 11.720 - 52 Week Range
9.650 - 16.200 - Volume
2,604,000 - Avg. Volume
8,168,645 - Market Cap (intraday)
19.987B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
18.85 - EPS (TTM)
0.600 - Earnings Date Aug 24, 2026
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
18.81
Recent News
View More
Performance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
9969.HK
7.82%
HANG SENG INDEX (^HSI)
8.95%
1-Year Return
9969.HK
17.98%
HANG SENG INDEX (^HSI)
11.21%
3-Year Return
9969.HK
83.31%
HANG SENG INDEX (^HSI)
34.07%
5-Year Return
9969.HK
39.45%
HANG SENG INDEX (^HSI)
8.04%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 10/27/2026
-
Market Cap
25.54B
-
Enterprise Value
19.73B
-
Trailing P/E
18.94
-
Forward P/E
91.31
-
PEG Ratio (current)
--
-
Price/Sales (ttm)
6.34
-
Price/Book (mrq)
2.10
-
Enterprise Value/Revenue
6.36
-
Enterprise Value/EBITDA
17.62
Financial Highlights
Profitability and Income Statement
-
Profit Margin
40.57%
-
Return on Assets (ttm)
7.12%
-
Return on Equity (ttm)
18.34%
-
Revenue (ttm)
3.36B
-
Net Income Avi to Common (ttm)
1.36B
-
Diluted EPS (ttm)
0.600
Balance Sheet and Cash Flow
-
Total Cash (mrq)
6.49B
-
Total Debt/Equity (mrq)
25.94%
-
Levered Free Cash Flow (ttm)
-966.07M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
27.660
-1.98%
Mkt Cap
HKD
10.333B
Industry
Biotechnology
426.200
-2.65%
Mkt Cap
HKD
101.872B
Industry
Biotechnology
15.450
-2.71%
Mkt Cap
HKD
15.85B
Industry
Biotechnology
